Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Juli 2010 12:52 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2010 Financial Results

CAMBRIDGE, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
27. Juli 2010 07:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Provides Update Regarding Generic Lovenox(R) Litigation

CAMBRIDGE, Mass., July 27, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
23. Juli 2010 12:05 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Conference Call Details Regarding Approval for Generic Lovenox(R)

CAMBRIDGE, Mass., July 23, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
23. Juli 2010 11:25 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces FDA Approval for First Generic Lovenox(R)

CAMBRIDGE, Mass., July 23, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
11. Juni 2010 11:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at Goldman Sachs 31st Annual Global Healthcare Conference

CAMBRIDGE, Mass., June 11, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
02. Juni 2010 16:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference

CAMBRIDGE, Mass., June 2, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
20. Mai 2010 13:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date for 2010 Annual Meeting of Stockholders

CAMBRIDGE, Mass., May 20, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
20. Mai 2010 13:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference

CAMBRIDGE, Mass., May 20, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
06. Mai 2010 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2010

CAMBRIDGE, Mass., May 6, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
28. April 2010 13:29 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2010 Financial Results

CAMBRIDGE, Mass., April 28, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report...

Vorherige Seite

Nächste Seite